Comparisons Between U.S. and EU Policies on Orphan Drugs
Comparisons Between U.S. and EU Policies on Orphan Drugs
USA: Approval of New Molecular Entity from 2001 to 2021
USA: Approval of New Molecular Entity from 2001 to 2021
Merger and Acquisition Deals by Therapeutic Area in Pharmaceutical and Healthcare Space (2018-2021)
Merger and Acquisition Deals by Therapeutic Area in Pharmaceutical and Healthcare Space (2018-2021)
EffRx Obtains Swiss Marketing Authorization for Bronchitol® in Cystic Fibrosis.
EffRx Pharmaceuticals SA, a commercial-stage company that commercializes niche and orphan medicines in Switzerland and Europe, announced today that Swissmedic had approved Bronchitol® (inhaled mannito ...
Pulmonary arterial hypertension (PAH) Thelansis comments
[vc_row][vc_column][vc_single_image image="4182" img_size="280x400" onclick="custom_link" title="Pulmonary arterial hypertension (PAH) Thelansis comments" link="https://thelansis.com/wp-content/upload ...
Biomarkers in rare diseases
Discovery of biomarkers in rare diseases: innovative approaches by predictive and personalized medicine Rare disease (or Orphan disease) is a collective terminology to define a group of conditions wit ...
Every day you learn something new
Suspendisse potenti nullam ac tortor vitae purus faucibus ornare suspendi sse. Et ultrices neque ornare aenean euismod elementum nisi quis eleifend. Neque egestas congue quisque egestas diam in arcu c ...
Why most small business fail in the last year?
Suspendisse potenti nullam ac tortor vitae purus faucibus ornare suspendi sse. Et ultrices neque ornare aenean euismod elementum nisi quis eleifend. Neque egestas congue quisque egestas diam in arcu c ...
Google Analytics checklist: is your website data accurate?
Suspendisse potenti nullam ac tortor vitae purus faucibus ornare suspendi sse. Et ultrices neque ornare aenean euismod elementum nisi quis eleifend. Neque egestas congue quisque egestas diam in arcu c ...